Hypothyroidism in Patients With Type 2 Diabetes With Early Diabetic Nephropathy

• Conditions: Hypothyroidism in Diabetes

• Registration Number: NCT03178253
• Lead Sponsor: Assiut University

Brief Summary

Diabetes Mellitus is the most common disorder seen. The impact of this disease on the quality of life, and on morbidity and mortality through the complications that affect the small and large vessels resulting in retinopathy, nephropathy, neuropathy, and ischemic heart disease has been emphasized by the findings of the national commission (USA) on diabetes .

So, there was curiosity to understand and learn the association of this disorder with another common endocrine gland function that is thyroid gland . The association between these two disorders has long been recognized although the prevalence of thyroid dysfunction in diabetic population varies widely between studies. With insulin and thyroid hormone being intimately involved in cellular metabolism and thus excess or deficit of these hormones result in functional derangement of the other.

Detailed Description

Diabetic patients have higher prevalence of thyroid disorder when compared with the normal population. Diabetic women are more frequently affected than men and hypothyroidism is more common than thyrotoxicosis .

Sub-clinical hypothyroidism is an independent risk factor for development of diabetic nephropathy. Severe hypothyroidism (biochemically) may be completely asymptomatic. Though our patient had throid stimulating hormone level more than 100 mIU/L, he did not have any symptoms of hypothyroidism.so diagnosis of hypothyroidism depends on laboratory parameters rather than clinical findings Recognition and treatment of hypothyroidism in diabetic patients will benefit glycemic control and improve general well-being ). Diabetic nephropathy, a major micro-vascular complication of type 2 diabetes mellitus, is an important cause of chronic kidney disease. It results from interactions between hemodynamic and metabolic factors .

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Status Verified: 2017-06
• Study First Submitted: 2017-06-03
• Study First Submitted QC: 2017-06-05
• Study First Posted: 2017-06-06
• Last Update Submitted: 2017-06-06
• Last Update Posted: 2017-06-07
• Study Start: 2017-06-30
• Primary Completion: 2017-06-30
• Study Completion: 2018-06-30

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• All patients with Type 2 diabetes mellitus and with diabetic nephropathy.
• All diabetics irrespective of glucose control.
• All diabetics irrespective of treatment (oral hypoglycemic drugs/insulin)

Read More

Exclusion Criteria

• 1. Type 1 diabetes mellitus 2) Patients with:

  • Gestational diabetes mellitus.
  • Pancreatitis.
  • Steroid induced Diabetes.
  • hepatobiliary disease
  • on systemic drug therapy such glucocorticoids and oral contraceptives.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
percentage of hypothyroidism in patients of type 2 diabetes with diabetic nephropathy	one year

Trial Locations

Locations (1)

Maria Hamdy; 🇪🇬 Assuit, Egypt